Organization
TapImmune, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
TapImmune, Inc.
... TapImmune Inc.(NASDAQ: TPIV), a clinical-stage immuno-oncology company, today announced that it has expanded its ...
... TapImmune Inc.(NASDAQ: TPIV), a clinical-stage immuno-oncology company, today announced that it has assembled a ...
... TapImmune Inc.(NASDAQ: TPIV), a leading clinical-stage immuno-oncology company, today announced that it will host ...
... TapImmune is planning to merge with T-cell therapy startup Marker Therapeutics. The agreement ...
... TapImmune Inc.(NASDAQ: TPIV) ("TapImmune") today announced that it has entered into a definitive merger ...
... TapImmune Inc.(NASDAQ: TPIV), a leading clinical-stage immuno-oncology company with ongoing clinical trials in ovarian ...
... TapImmune Inc.(NASDAQ: TPIV), a leading clinical-stage immuno-oncology company with ongoing clinical trials in ovarian ...
... and clinical update for the fourth quarter and year end 2017. About TapImmune Inc. TapImmune Inc. is a leader in the development of novel immunotherapies ...
... TapImmune Inc.(NASDAQ:TPIV), a leading clinical-stage immuno-oncology company with ongoing clinical trials in ovarian ...
Subscribe now for full coverage on TapImmune, Inc.
Start My Free Trial